Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) was down 8.1% during mid-day trading on Wednesday . The company traded as low as $6.34 and last traded at $6.37. Approximately 13,518 shares changed hands during trading, a decline of 23% from the average daily volume of 17,622 shares. The stock had previously closed at $6.93.
Fortress Biotech Price Performance
The firm’s 50-day simple moving average is $5.74 and its 200 day simple moving average is $8.05.
About Fortress Biotech
Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.
Featured Stories
- Five stocks we like better than Fortress Biotech
- Trading Stocks: RSI and Why it’s Useful
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- P/E Ratio Calculation: How to Assess Stocks
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
